Purpose: There are limited data at a population level on adjuvant brachytherapy (BT) practice for uterine corpus malignancies. The aims of the current study were to describe BT practice for this disease in New South Wales (NSW), to assess quality of BT, and to determine if a caseload effect on quality exists. Material and methods: Patient, tumour, and treatment related data were collected from all nine NSW radiation oncology departments that treated patients with BT. Included patients had malignancy of the uterine corpus with treat-ment including BT. Brachytherapy quality was assessed using published quality benchmarks. Higher gynaecological BT caseload departments were compared with lower caseload departments. Results: One hundred sixty-th...
William C Dooley1, John P Thropay2, Gary J Schreiber3, Mohamed Y Puthawala4, Steven C Lane5, James C...
INTRODUCTION: The purpose of this study is to describe the patterns of practice in Australia and New...
Objective: The PORTEC-4a trial investigates molecular-integrated risk profile guided adjuvant treatm...
Purpose: There are limited data at a population level on adjuvant brachytherapy (BT) practice for ut...
Purpose: We previously conducted modelling and a patterns of care study (POCS) that showed gynaecolo...
Introduction: Having previously modelled the optimal proportion of uterine cervix and corpus cancers...
Introduction: In Australia there is widespread underutilization of some cancer treatments and socioe...
Purpose: We aimed to estimate the optimal proportion of all gynecological cancers that should be tre...
Introduction: The purpose of this survey was to explore the current patterns of practice for brachyt...
Purpose: To determine current practice patterns with regard to gynecologic high-dose-rate (HDR) brac...
Purpose: Almost 30 % of malignancies in women of developing countries are gynecological and brachyth...
This article aims to review the risk stratification of endometrial cancer, treatment rationale, outc...
PURPOSE: To report survival outcomes in women with Stage II uterine endometrioid carcinoma who recei...
Background: To evaluate the current status of prospective interventional clinical trials that includ...
Objectives: The aim of this study was to examine the patterns of failure following adjuvant radiothe...
William C Dooley1, John P Thropay2, Gary J Schreiber3, Mohamed Y Puthawala4, Steven C Lane5, James C...
INTRODUCTION: The purpose of this study is to describe the patterns of practice in Australia and New...
Objective: The PORTEC-4a trial investigates molecular-integrated risk profile guided adjuvant treatm...
Purpose: There are limited data at a population level on adjuvant brachytherapy (BT) practice for ut...
Purpose: We previously conducted modelling and a patterns of care study (POCS) that showed gynaecolo...
Introduction: Having previously modelled the optimal proportion of uterine cervix and corpus cancers...
Introduction: In Australia there is widespread underutilization of some cancer treatments and socioe...
Purpose: We aimed to estimate the optimal proportion of all gynecological cancers that should be tre...
Introduction: The purpose of this survey was to explore the current patterns of practice for brachyt...
Purpose: To determine current practice patterns with regard to gynecologic high-dose-rate (HDR) brac...
Purpose: Almost 30 % of malignancies in women of developing countries are gynecological and brachyth...
This article aims to review the risk stratification of endometrial cancer, treatment rationale, outc...
PURPOSE: To report survival outcomes in women with Stage II uterine endometrioid carcinoma who recei...
Background: To evaluate the current status of prospective interventional clinical trials that includ...
Objectives: The aim of this study was to examine the patterns of failure following adjuvant radiothe...
William C Dooley1, John P Thropay2, Gary J Schreiber3, Mohamed Y Puthawala4, Steven C Lane5, James C...
INTRODUCTION: The purpose of this study is to describe the patterns of practice in Australia and New...
Objective: The PORTEC-4a trial investigates molecular-integrated risk profile guided adjuvant treatm...